Itemaren erregistro erraza erakusten du

dc.contributor.authorBorges, Gisela
dc.contributor.authorMiguélez Palomo, Cristina
dc.contributor.authorNeto, Fani
dc.contributor.authorMico, Juan Antonio
dc.contributor.authorUgedo Urruela, Luisa
dc.contributor.authorBerrocoso, Esther
dc.date.accessioned2018-05-31T14:53:03Z
dc.date.available2018-05-31T14:53:03Z
dc.date.issued2017-06
dc.identifier.citationInternational Journal of Neuropsychopharmacology 20(6) : 463-475 (2017)es_ES
dc.identifier.issn1461-1457
dc.identifier.issn1469-5111
dc.identifier.urihttp://hdl.handle.net/10810/27252
dc.description.abstractBackground: There is increasing evidence suggesting that the Locus Coeruleus plays a role in pain-related anxiety. Indeed, we previously found that prolonged arthritis produces anxiety-like behavior in rats, along with enhanced expression of phosphorylated extracellular signal-regulated kinase 1/2 (a marker of plasticity) in the Locus Coeruleus. However, it is unknown how this effect correlates with the electrophysiological activity of Locus Coeruleus neurons or pain-related anxiety. Methods: Using the complete Freund's adjuvant model of monoarthritis in male Sprague-Dawley rats, we studied the behavioral attributes of pain and anxiety as well as Locus Coeruleus electrophysiology in vivo 1 (MA1W) and 4 weeks (MA4W) after disease induction. Results: The manifestation of anxiety in MA4W was accompanied by dampened tonic Locus Coeruleus activity, which was coupled to an exacerbated evoked Locus Coeruleus response to noxious stimulation of the inflamed and healthy paw. When a mitogen-activating extracellular kinase inhibitor was administered to the contralateral Locus Coeruleus of MA4W, the phosphorylated extracellular signal-regulated kinase 1/2 levels in the Locus Coeruleus were restored and the exaggerated evoked response was blocked, reversing the anxiogenic-like behavior while pain hypersensitivity remained unaltered. Conclusion: As phosphorylated extracellular signal-regulated kinase 1/2 blockade in the Locus Coeruleus relieved anxiety and counteracted altered LC function, we propose that phosphorylated extracellular signal-regulated kinase 1/2 activation in the Locus Coeruleus plays a crucial role in pain-related anxiety.es_ES
dc.description.sponsorshipThis work was supported by the "Catedra Externa del Dolor Fundacion Grunenthal/Universidad de Cadiz," which paid a grant to the first author; the "Catedra em Medicina da Dor from Fundacao Grunenthal-Portugal and Faculdade de Medicina da Universidade do Porto"; co-financed by the Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa" (PI13/02659); the "Ministerio de Economia y Competitividad", co-financed byFEDER (SAF2015-68647-R (MINECO/FEDER)); CIBERSAM G18; the "Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia", Seville, Spain (CTS-510 and Proyecto de Excelencia: CTS-7748); 2015 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation; Fundacion Espanola de Dolor (travel fellowship granted to Gisela Borges - 1536); and Gobierno Vasco (IT747-13).es_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.relationinfo:eu-repo/grantAgreement/MINECOes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectLocus Coeruleuses_ES
dc.subjectanxietyes_ES
dc.subjectpaines_ES
dc.subjectarthritises_ES
dc.subjectERK1/2es_ES
dc.subjectcorticotropin-releasing-factores_ES
dc.subjectforced swimming testes_ES
dc.subjectnoradrenergic systemes_ES
dc.subjectmonoarthritic ratses_ES
dc.subjectneuronses_ES
dc.subjectmodulationes_ES
dc.subjectstresses_ES
dc.subjectmodeles_ES
dc.subjectantidepressantes_ES
dc.subjectdepressiones_ES
dc.titleActivation of Extracellular Signal-Regulated Kinases (ERK 1/2) in the Locus Coeruleus Contributes to Pain-Related Anxiety in Arthritic Male Ratses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comes_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://academic.oup.com/ijnp/article/20/6/463/2965639es_ES
dc.identifier.doi10.1093/ijnp/pyx005
dc.departamentoesFarmacologíaes_ES
dc.departamentoeuFarmakologiaes_ES


Item honetako fitxategiak

Thumbnail
Thumbnail

Item hau honako bilduma honetan/hauetan agertzen da

Itemaren erregistro erraza erakusten du

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Bestelakorik adierazi ezean, itemaren baimena horrela deskribatzen da:This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com